These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18331305)

  • 21. New therapies for hepatitis C virus infection.
    Soriano V; Peters MG; Zeuzem S
    Clin Infect Dis; 2009 Feb; 48(3):313-20. PubMed ID: 19123867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria.
    Semira ; Wafai ZA; Zulfkar Q; Sameem F
    Indian J Pharmacol; 2014; 46(4):438-40. PubMed ID: 25097286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced livedo and the EGFR pathway.
    de Saint Martin L; Pasquier E
    Eur J Dermatol; 2008; 18(5):601-3. PubMed ID: 18779114
    [No Abstract]   [Full Text] [Related]  

  • 24. Is {beta}-interferon a promising therapeutic option for the management of hepatitis C?
    Hosseini-Moghaddam SM; Mousavi A; Alavian SM
    J Antimicrob Chemother; 2009 Jun; 63(6):1097-103. PubMed ID: 19329508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
    Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
    Shinohara MM; Davis C; Olerud J
    J Drugs Dermatol; 2009 Sep; 8(9):870-2. PubMed ID: 19746680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
    Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to use virological tools for optimal management of chronic hepatitis C.
    Chevaliez S; Pawlotsky JM
    Liver Int; 2009 Jan; 29 Suppl 1():9-14. PubMed ID: 19207960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure.
    Dai CY; Chuang WL; Huang JF; Hsieh MY; Yu ML
    Hepatology; 2008 Aug; 48(2):692-3; author reply 693-4. PubMed ID: 18666250
    [No Abstract]   [Full Text] [Related]  

  • 31. Anticholinergic syndrome with severe rhabdomyolysis--an unusual feature of amantadine toxicity.
    Yang CC; Deng JF
    Intensive Care Med; 1997 Mar; 23(3):355-6. PubMed ID: 9083247
    [No Abstract]   [Full Text] [Related]  

  • 32. Livedo reticularis with retiform purpura associated with gefitinib (Iressa).
    Blume JE; Miller CC
    Int J Dermatol; 2007 Dec; 46(12):1307-8. PubMed ID: 18173531
    [No Abstract]   [Full Text] [Related]  

  • 33. Livedo reticularis during amantadine treatment.
    Vollum DI; Parkes JD; Doyle D
    Br Med J; 1971 Jun; 2(5762):627-8. PubMed ID: 5580722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe reversible neurological complications following amantadine treatment in three elderly patients with renal insufficiency.
    Nakata M; Ito S; Shirai W; Hattori T
    Eur Neurol; 2006; 56(1):59-61. PubMed ID: 16921246
    [No Abstract]   [Full Text] [Related]  

  • 36. Painful subcutaneous nodules in a patch of livedo reticularis.
    Barnes P; Chapman C; Fett N
    Int J Dermatol; 2017 Mar; 56(3):e44-e46. PubMed ID: 27496315
    [No Abstract]   [Full Text] [Related]  

  • 37. Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy.
    Gallegos-Orozco JF; Werner KT; Rosati M; Byrne TJ; Balan V; Vargas HE; Rakela J
    Am J Gastroenterol; 2008 Aug; 103(8):2161-2. PubMed ID: 18796126
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical use of interferon in hepatitis B and C.
    Schalm SW
    Verh K Acad Geneeskd Belg; 2009; 71(1-2):87-99. PubMed ID: 19739400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Livedo reticularis induced by amantadine.
    Sladden MJ; Nicolaou N; Johnston GA; Hutchinson PE
    Br J Dermatol; 2003 Sep; 149(3):656-8. PubMed ID: 14511008
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical studies of antiviral agents].
    Kitamoto O
    Naika; 1970 Sep; 26(3):404-8. PubMed ID: 5473946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.